82% Of Pfizer Vaccine Purchased From Rich Countries So What’s Left For The Poor
Just two days after pharmaceutical giant Pfizer shared the positive early results of the CORONA vaccine trial, mass purchases of a vaccine by the world’s richest countries left more than 85% of the world’s population, the poorest, without any means to obtain it.
READ ALSO: Arrest of young man who beat the muezzin of an archeological mosque in Lebanon
Activists in the UK warned on Wednesday that poor countries would long suffer from the coronavirus, despite the availability of the vaccine, and called for a change in global patent laws that make vaccine production the preserve of the company that discovered it.
“This can be achieved through the support of governments such as South Africa and India that are trying to suspend the WTO’s intellectual property rules during the world’s state of emergency.”
The World Justice Organization reiterated its call for the suspension of global patent rules to enable poor countries to develop similar versions of pfizer vaccine at lower prices. South Africa and India also proposed last month that the World Trade Organization (WTO) suspend intellectual property rules for vaccines and treatments related to COFD19.
Pfizer says that by the end of 2021 it will be able to produce 1.35 billion doses of the vaccine, which has been shown to be 90% effective in preventing MERS infection in patients who have never been infected with the virus. More than 1 billion doses, representing 82% of the supply, have already been purchased by rich countries.